Covidh (COVIDH.BO) Stock
Covidh

Company profile
Covidh reported no revenue for fiscal year 2025. In Q3 2026 (the quarter ended December 31, 2025) revenue was 1.93 million INR. In Q3 2026 it reported a net loss of 2.82 million INR, against a net loss of 665,000 INR a year earlier.
What stands out
- It returned to a profit in fiscal year 2025, 1.39 million INR, after 3 years of net losses (942,000 INR in fiscal year 2024).
- Its average diluted share count rose 6.8% in fiscal year 2025, from 0.3 million to 0.3 million shares.
Figures from company filings; latest fiscal year ended March 31, 2025.
About Covidh
iSERA Lifesciences Limited engages in the IT/ITES business in India. The company was formerly known as Covidh Technologies Limited and changed its name to iSERA Lifesciences Limited in April 2026. The company was incorporated in 1993 and is based in Pune, India.
Leadership
- Vishal Jain — Chief Financial Officer
- Jayshree Suresh Babulal Jain — MD & Director, 45
- Deepakshi - — Company Secretary & Compliance Officer
- Jitendra Prabhakar Nene — Executive Director, 56
- Dhairyasheel Vasantrao Yadav — Executive Director
What companies are similar to Covidh?
Listed companies of a similar size in the same industry (IT advisory services) include Reliable Data Services Limited (RELIABLE.NS), Dev Information Technology Limited (DEVIT.NS), Cranes Software International Limited (CRANESSOFT.BO), Titan Intech Limited (TITANIN.BO).
Has Covidh made a profit in recent years?
Net income by fiscal year: FY2022, a loss of 1.06 million INR; FY2023, a loss of 1.12 million INR; FY2024, a loss of 942,000 INR; FY2025, 1.39 million INR. It reported a net loss in 3 of these 4 years.
Company Information
Contact & Links
Data as of .
How to cite: DataPorium, “Covidh (COVIDH.BO)”, data as of Dec 31, 2025, https://dataporium.tech/stocks/COVIDH.BO